Transforming the future of medicine through scientific excellence

Since its inception, the Australian Regenerative Medicine Institute has been a hub for innovative research into regenerative biology and repair, with the goal of developing regenerative medicines and advanced therapies.

With scientific excellence, high quality evidence and thought leadership core to everything we do, our research has resulted in high-impact publications, early-stage therapeutic products on the commercialisation pathway and clinical trials. ARMI’s globally respected leaders and rising stars define our culture of excellence, commitment, collaboration and care.

ARMI is Australia’s flagship Institute in regenerative medicine and advanced therapies with 16 research groups and over 200 staff and students from 21 different countries.

In 2020, ARMI attracted $7.7 million in research income in competitive and non-competitive schemes, with the majority of this funding from the funding agencies of the Australian Government, National Health and Medicine Research Council and Australian Research Council.

Read more about our achievements in the ARMI Annual Report 2024.

Find out more about our research leadership groups here.